Commensurate with this evidence, Co-workers and Saito confirmed that Nrf2-activating phosphorylation from the p62 KIR domain increases chemoresistance, malignancy and proliferation of HCC, confirming the cancer defensive function of p62-reliant Nrf2 activation [13]

Commensurate with this evidence, Co-workers and Saito confirmed that Nrf2-activating phosphorylation from the p62 KIR domain increases chemoresistance, malignancy and proliferation of HCC, confirming the…